RegDesk Regulatory Roundup

MHRA on borderline products Europe

MHRA on borderline products

The article describes the approach to be applied when determining the regulatory status of a borderline product that could be subject to regulation under the medical devices framework, and also pays special attention to the applicable risk-based classification. Table...

Read More

FDA on MDDT (qualification phase) FDA

FDA on MDDT (qualification phase)

The new article highlights aspects related to the second stage of the application review process and also describes the approach to be applied when making changes to a tool after its qualification. Table of Contents The Food and Drug Administration (FDA or the...

Read More

FDA on MDDT (proposal phase) FDA

FDA on MDDT (proposal phase)

The new article addresses aspects related to the initial proposal and the way it will be assessed by the authority during the acceptance review. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of...

Read More